24
Jun
Cilcare is pleased to announce that its innovative INEAR3D project has been selected by the Companies & Campus initiative, supported by the University of Montpellier and its Pôle Universitaire d’Innovation (PEI). The project has received a €50,000 grant in recognition of its scientific impact and alignment with the PEI’s health and sustainability priorities.
Led by Dr. Sylvie Pucheu, Director of Preclinical Innovation at Cilcare, INEAR3D represents a bold leap forward in the development of human-based in vitro models for auditory drug screening. The project is carried out in collaboration with the Institut Charles...